Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Potassium Iodide | HCID 4875 | — |
| Reactant | 1-Phenylpiperazine | HCID 7096 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | HCID 13808652 | HCID 13808652 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 86749652 | HCID 86749652 | — |
Reaction Steps
A mixture of 4-(3-chloropropyl)-7-methoxy-3,4-dihydro-2H-1,5-benzoxathiepin-3-ol (500 mg), N-phenylpiperazine (500 mg), potassium iodide (50 mg), potassium carbonate (400 mg) and N,N-dimethylformamide (10 ml) was stirred at 80° C for 8 hours. Water was added to the reaction mixture and the mixture was extracted with ethyl acetate. The organic layer was washed with water and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (eluent: hexaneethyl acetate-methanol=10:10:1), and a colorless oil obtained was converted to hydrochloride and recrystallized from methanol-acetone to give a white powder of cis 7-methoxy-4-[3(4-phenylpiperazin-1-yl)propyl]-3,4-dihydro-2H-1,5-benzoxathiepin-3-ol dihydrochloride obtained in Reference Example 26.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05538974 |
|---|
| Source dataset | uspto-grants-1996_07 |
|---|
| ORD ID | ord-16684eed67b54afab7da92ecf4dc26dc |
|---|
| Source note | uspto-grants-1996_07 |
|---|